US Stock MarketDetailed Quotes

XORTX Therapeutics (XRTX)

Watchlist
  • 2.010
  • -0.330-14.10%
Close May 14 15:59 ET
  • 2.000
  • -0.010-0.50%
Post 17:31 ET
3.11MMarket Cap-0.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

XORTX Therapeutics (XRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.94%3.26M
3.80%686.42K
-18.13%716.2K
-40.42%889.95K
-11.50%963.46K
-31.88%4.12M
-32.78%661.26K
-37.22%874.75K
-15.21%1.49M
-42.92%1.09M
Selling and administrative expenses
-19.79%1.83M
21.64%495.11K
-28.12%392.94K
-43.05%465.83K
-6.71%477.8K
2.51%2.28M
-16.05%407.03K
7.16%546.63K
13.24%817.91K
0.33%512.15K
-General and administrative expense
-19.79%1.83M
21.64%495.11K
-28.12%392.94K
-43.05%465.83K
-6.71%477.8K
2.51%2.28M
-16.05%407.03K
7.16%546.63K
13.24%817.91K
0.33%512.15K
Research and development costs
212.75%574.94K
606.74%54.86K
64.10%57.01K
175.92%186.75K
275.20%276.31K
-92.40%183.83K
-94.21%7.76K
-93.90%34.74K
-89.87%67.68K
-92.97%73.64K
Depreciation amortization depletion
-4.40%112.12K
11.36%29.12K
13.24%29.39K
-16.40%27.63K
-19.13%25.99K
-16.05%117.27K
7.32%26.14K
57.58%25.95K
3.21%33.05K
-51.93%32.13K
-Depreciation and amortization
-4.40%112.12K
11.36%29.12K
13.24%29.39K
-16.40%27.63K
-19.13%25.99K
-16.05%117.27K
7.32%26.14K
57.58%25.95K
3.21%33.05K
-51.93%32.13K
Other operating expenses
-51.92%737.29K
-51.29%107.33K
-11.43%236.86K
-63.53%209.74K
-61.04%183.37K
21.72%1.53M
-35.26%220.32K
-9.96%267.43K
69.40%575.05K
66.30%470.7K
Operating profit
20.94%-3.26M
-3.80%-686.42K
18.13%-716.2K
40.42%-889.95K
11.50%-963.46K
31.88%-4.12M
32.78%-661.26K
37.22%-874.75K
15.21%-1.49M
42.92%-1.09M
Net non-operating interest income expense
-65.65%41.87K
-84.52%3.92K
-75.19%7.2K
-65.72%12.33K
-41.71%18.42K
-51.92%121.91K
-49.15%25.33K
-54.38%29.02K
-50.96%35.95K
-52.69%31.6K
Non-operating interest income
-65.65%41.87K
-84.52%3.92K
-75.19%7.2K
-65.72%12.33K
-41.71%18.42K
-51.92%121.91K
-49.15%25.33K
-54.38%29.02K
-50.96%35.95K
-52.69%31.6K
Total other finance cost
65.65%-41.87K
----
----
----
----
51.92%-121.91K
----
----
----
----
Other net income (expense)
-18.33%557.84K
-87.87%92.03K
-76.99%59.53K
-90.18%159.92K
112.56%246.36K
-81.21%683.07K
-79.12%758.47K
7,153.30%258.72K
46,688.55%1.63M
-23,298.79%-1.96M
Gain on sale of security
-18.06%559.67K
-87.62%93.87K
-76.99%59.53K
-90.18%159.92K
112.56%246.36K
-81.21%683.07K
-79.12%758.47K
7,153.30%258.72K
46,688.55%1.63M
-23,298.79%-1.96M
Special income (charges)
---1.83K
----
----
----
----
--0
----
----
----
----
-Less：Restructuring and merger&acquisition
----
----
----
----
----
--279.03K
----
----
----
----
-Less:Impairment of capital assets
--1.83K
----
----
----
----
--0
----
----
----
----
Income before tax
19.83%-2.66M
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
Income tax
Net income
19.83%-2.66M
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
Net income continuous Operations
19.83%-2.66M
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
Minority interest income
Net income attributable to the parent company
19.83%-2.66M
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.83%-2.66M
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.7K
76.86%-698.67K
-53.53%-3.31M
-95.46%122.54K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
Basic earnings per share
51.30%-2.8
-160.00%-0.3
35.00%-0.65
-416.67%-0.95
84.68%-0.95
-5.50%-5.75
-92.70%0.5
70.15%-1
107.06%0.3
-30.53%-6.2
Diluted earnings per share
51.30%-2.8
-160.00%-0.3
35.00%-0.65
-416.67%-0.95
84.68%-0.95
-5.50%-5.75
-92.70%0.5
70.15%-1
107.06%0.3
-30.53%-6.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -20.94%3.26M3.80%686.42K-18.13%716.2K-40.42%889.95K-11.50%963.46K-31.88%4.12M-32.78%661.26K-37.22%874.75K-15.21%1.49M-42.92%1.09M
Selling and administrative expenses -19.79%1.83M21.64%495.11K-28.12%392.94K-43.05%465.83K-6.71%477.8K2.51%2.28M-16.05%407.03K7.16%546.63K13.24%817.91K0.33%512.15K
-General and administrative expense -19.79%1.83M21.64%495.11K-28.12%392.94K-43.05%465.83K-6.71%477.8K2.51%2.28M-16.05%407.03K7.16%546.63K13.24%817.91K0.33%512.15K
Research and development costs 212.75%574.94K606.74%54.86K64.10%57.01K175.92%186.75K275.20%276.31K-92.40%183.83K-94.21%7.76K-93.90%34.74K-89.87%67.68K-92.97%73.64K
Depreciation amortization depletion -4.40%112.12K11.36%29.12K13.24%29.39K-16.40%27.63K-19.13%25.99K-16.05%117.27K7.32%26.14K57.58%25.95K3.21%33.05K-51.93%32.13K
-Depreciation and amortization -4.40%112.12K11.36%29.12K13.24%29.39K-16.40%27.63K-19.13%25.99K-16.05%117.27K7.32%26.14K57.58%25.95K3.21%33.05K-51.93%32.13K
Other operating expenses -51.92%737.29K-51.29%107.33K-11.43%236.86K-63.53%209.74K-61.04%183.37K21.72%1.53M-35.26%220.32K-9.96%267.43K69.40%575.05K66.30%470.7K
Operating profit 20.94%-3.26M-3.80%-686.42K18.13%-716.2K40.42%-889.95K11.50%-963.46K31.88%-4.12M32.78%-661.26K37.22%-874.75K15.21%-1.49M42.92%-1.09M
Net non-operating interest income expense -65.65%41.87K-84.52%3.92K-75.19%7.2K-65.72%12.33K-41.71%18.42K-51.92%121.91K-49.15%25.33K-54.38%29.02K-50.96%35.95K-52.69%31.6K
Non-operating interest income -65.65%41.87K-84.52%3.92K-75.19%7.2K-65.72%12.33K-41.71%18.42K-51.92%121.91K-49.15%25.33K-54.38%29.02K-50.96%35.95K-52.69%31.6K
Total other finance cost 65.65%-41.87K----------------51.92%-121.91K----------------
Other net income (expense) -18.33%557.84K-87.87%92.03K-76.99%59.53K-90.18%159.92K112.56%246.36K-81.21%683.07K-79.12%758.47K7,153.30%258.72K46,688.55%1.63M-23,298.79%-1.96M
Gain on sale of security -18.06%559.67K-87.62%93.87K-76.99%59.53K-90.18%159.92K112.56%246.36K-81.21%683.07K-79.12%758.47K7,153.30%258.72K46,688.55%1.63M-23,298.79%-1.96M
Special income (charges) ---1.83K------------------0----------------
-Less：Restructuring and merger&acquisition ----------------------279.03K----------------
-Less:Impairment of capital assets --1.83K------------------0----------------
Income before tax 19.83%-2.66M-581.87%-590.46K-10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M
Income tax
Net income 19.83%-2.66M-581.87%-590.46K-10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M
Net income continuous Operations 19.83%-2.66M-581.87%-590.46K-10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M
Minority interest income
Net income attributable to the parent company 19.83%-2.66M-581.87%-590.46K-10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.83%-2.66M-581.87%-590.46K-10.64%-649.47K-522.01%-717.7K76.86%-698.67K-53.53%-3.31M-95.46%122.54K55.98%-587.01K110.05%170.07K-64.79%-3.02M
Basic earnings per share 51.30%-2.8-160.00%-0.335.00%-0.65-416.67%-0.9584.68%-0.95-5.50%-5.75-92.70%0.570.15%-1107.06%0.3-30.53%-6.2
Diluted earnings per share 51.30%-2.8-160.00%-0.335.00%-0.65-416.67%-0.9584.68%-0.95-5.50%-5.75-92.70%0.570.15%-1107.06%0.3-30.53%-6.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -